New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
Long drug-eluting stent: Boston Scientific plans to launch its Taxus Liberte Long paclitaxel-eluting coronary stent in August after receiving PMA approval on July 16, the firm states. Taxus Liberte Long is 38 mm, the longest available drug eluting stent, according to the company. It is designed to treat the estimated 8-10% of patients with long lesions more efficiently than multiple shorter stents, the firm says. Taxus Liberte Long, which received a CE Mark in 2007, significantly reduced myocardial infarction when compared to Taxus Express in the ATLAS long lesion trial, the company notes (1"The Gray Sheet" Feb. 9, 2009)